site stats

Genfit press release

WebDec 31, 2024 · This press release contains certain forward-looking statements with respect to GENFIT, including those within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding GENFIT’s research and development programs and planned release of financial information. WebGENFIT 885 Avenue Eugène Avinée, 59120 Loos - FRANCE +333 2016 4000 www.genfit.com 1 PRESS RELEASE GENFIT Reports Full-Year 2024 Financial Results and Provides Corporate Update • Cash and cash equivalents totaled €258.8 million as of December 31, 2024 • Major financial achievements in 2024 include landmark strategic …

GENFIT: Provides Initial Update on Corporate Strategy Nasdaq

WebApr 7, 2024 · Lille, France; Cambridge, MA; April 7, 2024 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of … WebJan 24, 2024 · GENFIT annonce son calendrier financier pour 2024. Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 24 janvier 2024 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des patients atteints de maladies du foie dont les besoins … hardware administration https://blufalcontactical.com

GENFIT to Acquire Clinical-stage Biopharmaceutical

WebDec 17, 2024 · Paris (France), 17 December 2024 – Ipsen (Euronext: IPN; ADR: IPSEY) and GENFIT (Nasdaq and Euronext: GNFT) have entered into a long-term strategic … WebLille (France), Cambridge (Massachusetts, United States), March 10, 2016– GENFIT (Euronext: GNFT – ISIN: FR0004163111), a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announced that it has … WebMay 11, 2024 · This press release contains certain forward-looking statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995, with … changemyaddress

GENFIT and LabCorp Sign a Licensing Agreement to Expand …

Category:GENFIT Reports Full-Year 2024 Financial Results and Provides Corporat…

Tags:Genfit press release

Genfit press release

Data from Phase 2b trial of GENFIT’s Elafibranor published in ...

WebJan 24, 2024 · This press release contains certain forward-looking statements with respect to GENFIT, including those within the meaning of the Private Securities Litigation Reform Act of 1995, in relation to ... WebMay 11, 2024 · Lille (France), Cambridge (Massachusetts, United States), May 11, 2024– GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company …

Genfit press release

Did you know?

Web15 hours ago · GENFIT tiendra une conférence téléphonique en anglais et en français le 14 avril 2024 à 08h00 ET / 13h00 GMT / 14h00 CET . Les deux conférences téléphoniques … WebApr 29, 2024 · Lille, France; Cambridge, MA; April 29,2024- GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of …

WebDec 31, 2024 · Lille, France; Cambridge, MA; January 24, 2024- GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with severe chronic liver diseases, today announced its provisional financial calendar for 2024. This calendar is subject to change. ABOUT GENFIT WebJean-François Mouney, chairman & CEO of GENFIT, commented: “We are very enthusiastic to announce this agreement, which represents a major step in GENFIT’s commercial …

WebThis press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in GENFIT in any country. This … Web15 hours ago · This press release contains certain forward-looking statements with respect to GENFIT, including those within the meaning of the Private Securities Litigation Reform …

WebJul 22, 2024 · Complete corporate strategy update to be announced end of September 2024. Lille (France), Cambridge (Massachusetts, United States), July 22, 2024– GENFIT …

WebDec 17, 2024 · GENFIT CONTACT. GENFIT Investors. Tel: +33 3 2016 4000 [email protected]. PRESS RELATIONS Media. Stephanie Boyer – Press relations Tel: +333 2016 4000 [email protected]. References * With the exception of China, Hong Kong, Taiwan, and Macau where Terns Pharmaceuticals holds the … change mute hotkey teamsWebJan 24, 2024 · This press release contains certain forward-looking statements with respect to GENFIT, including those within the meaning of the Private Securities Litigation Reform Act of 1995, in relation... change my account name windows 11WebSep 28, 2024 · LILLE, FRANCE; CAMBRIDGE, MA; & BURLINGTON, N.C.—Sep. 28, 2024— GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases, and LabCorp® (NYSE:LH), a leading global life sciences company that is focused on advancing health … hardware address windows 10Web15 hours ago · Genfit press release (GNFT): FY GAAP EPS of -€0.48.Revenue of €26.57M (-69.0% Y/Y). change my account name on pcWebGenfit press release ( NASDAQ: GNFT ): FY GAAP EPS of -€0.48. Revenue of €26.57M (-69.0% Y/Y). Now read: Numinus Wellness GAAP EPS of -C$0.03, revenue of C$5.35M … change my account phone numberWebDec 17, 2024 · Paris (France); December 17, 2024, Ipsen (Euronext: IPN; ADR: IPSEY) and GENFIT (Nasdaq and Euronext: GNFT), have entered into a long-term strategic … change my account numberWebFeb 11, 2016 · With facilities in Lille, France, and Cambridge, MA (USA), the Company has approximately 100 employees. GENFIT is a public company listed in compartment B of Euronext’s regulated market in Paris (Euronext: GNFT – ISIN: FR0004163111). www.genfit.com. Disclaimer: This press release contains certain forward-looking … change my account password